Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2005
05/12/2005US20050101530 Cellular virus receptors and methods of use
05/12/2005US20050100954 Fluorescent proteins from aquatic species
05/12/2005US20050100924 C/EBPalpha gene targeting constructs and uses thereof
05/12/2005US20050100884 Using nematode model to identify modulator for prevention and treatment of vesicular stomatitis virus infection
05/12/2005US20050100532 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
05/12/2005CA2543966A1 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005CA2543522A1 Phosphodiesterase 9 inhibition as treatment for obesity-related conditions
05/12/2005CA2543058A1 Transgenic flies expressing mutant a.beta.42
05/12/2005CA2538695A1 Clq related protein
05/11/2005EP1377159B1 Products and methods for improving animal dental hygiene
05/11/2005CN2698075Y Larva fodder separating tank of house fly breeding
05/11/2005CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor
05/11/2005CN1615356A Method and system for fusion and activation following nuclear transfer in reconstructed embryos
05/11/2005CN1613305A Cony fur containing biological active substances and use thereof
05/11/2005CN1613304A Biological ecological three-dimensional culturing cases
05/11/2005CN1613301A Culture of corbicula fluminea in rice field
05/11/2005CN1201001C Process of cell reprogramming
05/11/2005CN1200735C Model animal of mesangial cell proliferative nephritis
05/11/2005CN1200603C Method for increasing incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat
05/10/2005US6891082 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
05/10/2005US6891081 Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof
05/10/2005US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/10/2005US6890731 For drug screeing/therapy of diseases; bacteriophages
05/10/2005US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas
05/06/2005WO2005040383A1 B lymphoid lineage specific promoter sequences and pharmaceutical compositions containing the same
05/06/2005WO2005039282A1 Drosophila transgenic animal models for the treatment of human genetic diseases caused by expansions of microsatellites which contain the trinucleotide ctg
05/06/2005WO2005004592A3 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
05/06/2005WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
05/06/2005WO2004093830A3 Model for neurodegenerative disorders
05/06/2005WO2003062394A3 Methods and compositions for rna interference
05/06/2005CA2543786A1 Methods and systems for inferring traits to manage non-beef livestock
05/06/2005CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
05/06/2005CA2535836A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences
05/05/2005US20050097627 Transgenic ungulates having reduced prion protein activity and uses thereof
05/05/2005US20050097625 Generating trangenic mammal in which somatic and germ cell comprisie heavy chain variable region of immunoglobulins; bioreactors for production of preferential immunoglobulins in milk
05/05/2005US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
05/05/2005US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics
05/05/2005US20050095713 Vectors for gene mutagenesis and gene discovery
05/05/2005US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
05/05/2005US20050095650 screening for an agent that modulates capsaicin receptor function
05/05/2005US20050095643 Determining gene function and essentiality via inhibition analysis; pathogen selected therapies
05/05/2005US20050095199 protecting against parasites and predators; transgenic organisims
05/04/2005EP1527176A2 Further novel forms of interfering rna molecules
05/04/2005CN2696322Y Hanging type automatic rotary grid cluster for silkworm
05/04/2005CN2696321Y Multi-purpose culturing box for yellow meal worm
05/04/2005CN1612931A Genetic manipulation method
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1611111A Culturing articles for non-concentrated bait and its production method
05/04/2005CN1200107C Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei
05/03/2005US6888047 Animal models for drug production in vivo; treatment of human diseases; genetic engineering
05/03/2005US6887983 Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
05/03/2005US6887674 Artery- and vein-specific proteins and uses therefor
04/2005
04/28/2005WO2005038027A1 Transgenic nonhuman mammal
04/28/2005WO2005038001A2 Improved transgenesis by sperm-mediated gene transfer
04/28/2005WO2005037994A2 Transgenic rodents selectively expressing human b1 bradykinin receptor protein
04/28/2005WO2005037191A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals
04/28/2005WO2005013889A3 Truncated fragments of alpha-synuclein in lewy body disease
04/28/2005WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
04/28/2005WO2005000093A3 Methods for screening therapeutic agents for serotonin related diseases and other disorders
04/28/2005WO2003095971A3 Posh nucleic acids, polypeptides and related methods
04/28/2005WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
04/28/2005US20050091709 Transgenic organism epressing fungal mrp-like abc transporters
04/28/2005US20050091704 transgenic mouse in which the Ant2 gene is inactivated in the liver; thought to be an integral component of the mitochondrial permeability transition pore
04/28/2005US20050091703 Nonhuman model animal of th2-mediated hyperimmune response
04/28/2005US20050091702 Expression of polypeptides in rod outer segment membranes
04/28/2005US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody
04/28/2005US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents
04/28/2005US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models:
04/28/2005US20050090001 Cell lines and methods for producing proteins
04/28/2005US20050089981 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated
04/28/2005US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
04/28/2005US20050089887 Novel human ion channel proteins
04/28/2005US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes
04/28/2005US20050089871 G protein-related kinase mutants in essential hypertension
04/28/2005US20050089865 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils
04/28/2005US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders
04/28/2005US20050089518 Prospective identification and characterization of breast cancer stem cells
04/28/2005CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption
04/28/2005CA2540210A1 Transgenic rodents selectively expressing human b1 bradykinin receptor protein
04/28/2005CA2538722A1 Expression of dominant negative transmembrane receptors in the milk of transgenic animals
04/27/2005EP1526184A1 Promoter sequences specific for cells of the B lymphoid lineage and pharmaceutical compositions containing the same
04/27/2005EP1526141A2 MHC complexes and uses thereof
04/27/2005EP1525466A2 Transgenic mammals expressing polyglutamine
04/27/2005EP1525465A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
04/27/2005EP1525314A2 Multi-reporter gene model for toxicological screening
04/27/2005EP1525311A2 Protein complexes of the tip60 transcriptional activator protein as well as components, fragments and derivatives thereof and methods for using the same
04/27/2005EP1241934A4 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight
04/27/2005EP0783572B1 Promoter for the receptor tyrosine kinase, tie
04/27/2005CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
04/27/2005CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema
04/27/2005CN1608456A Earthworm excrement deodorizing method and apparatus
04/27/2005CN1198938C Characterisation of gene function using double stranded RNA inhibition
04/26/2005US6884779 Hybrid screening analyzing
04/26/2005US6884775 Methods and compositions for regulating skeletogenic formation
04/26/2005US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
04/21/2005WO2005035729A2 A genetic screen in drosophila for metastatic behavior
04/21/2005WO2005025310A3 MODEL SYSTEM FOR TCR ξ CHAIN DOWNREGULATION
04/21/2005WO2005012517A3 Use of the fret phenomenon for in vivo follow-up of biological events
04/21/2005WO2004113501A3 Methods and compositions relating to lipid accumulation
04/21/2005WO2004098490A3 Mesoderm and definitive endoderm cell populations